CHI Advisors

Latest statistics and disclosures from CHI Advisors's latest quarterly 13F-HR filing:

Portfolio Holdings for CHI Advisors

Companies in the CHI Advisors portfolio as of the June 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Repare Therapeutics Ord 30.30 $77.66M +317% 2.50M 31.02
Pliant Therapeutics 29.21 $74.85M 2.31M 32.46
Akouos 8.56 $21.94M +457% 974.99k 22.50
Keros Therapeutics 8.49 $21.75M 579.74k 37.51
Larimar Therapeutics 7.60 $19.47M -29% 1.52M 12.85
Orchard Therapeutics Ads (ORTX) 6.86 $17.59M 2.93M 6.00
Precision Biosciences Ord (DTIL) 3.12 $8.00M 960.04k 8.33
Ovid Therapeutics (OVID) 1.57 $4.01M 544.28k 7.37
Kezar Life Sciences (KZR) 0.69 $1.77M 340.97k 5.18
Myokardia (MYOK) 0.51 $1.30M 13.50k 96.59
Livongo Health (LVGO) 0.44 $1.13M 15.00k 75.20
G1 Therapeutics (GTHX) 0.42 $1.07M 44.00k 24.25
Adverum Biotechnologies (ADVM) 0.41 $1.04M 50.00k 20.88
Ultragenyx Pharmaceutical (RARE) 0.40 $1.02M 13.00k 78.23
Corvus Pharmaceuticals (CRVS) 0.39 $990.00k 364.13k 2.72
Blueprint Medicines (BPMC) 0.37 $936.00k 12.00k 78.00
Global Blood Therapeutics In (GBT) 0.32 $821.00k 13.00k 63.15
Bluebird Bio (BLUE) 0.19 $488.00k 8.00k 61.00
Unum Therapeutics Ord (UMRX) 0.17 $432.96k 940.80k 0.46

Past Filings by CHI Advisors

SEC 13F filings are viewable for CHI Advisors going back to 2019